245 related articles for article (PubMed ID: 31838464)
1. Microvasculature Changes of Myopic Choroidal Neovascularization and the Predictive Value of Feeder Vessel Disappearance after Ranibizumab Treatment Revealed Using Optical Coherence Tomography Angiography.
Giorno P; Iacono P; Scarinci F; Di Renzo A; Varano M; Parravano M
Ophthalmologica; 2020; 243(4):263-270. PubMed ID: 31838464
[TBL] [Abstract][Full Text] [Related]
2. HOW VITREOMACULAR INTERFACE MODIFIES THE EFFICACY OF ANTI-VEGF THERAPY FOR MYOPIC CHOROIDAL NEOVASCULARIZATION.
Iacono P; Battaglia Parodi M; Iuliano L; Bandello F
Retina; 2018 Jan; 38(1):84-90. PubMed ID: 28098725
[TBL] [Abstract][Full Text] [Related]
3. Optical coherence tomography angiography in myopic choroidal neovascularization after intravitreal ranibizumab.
Cennamo G; Amoroso F; Schiemer S; Velotti N; Alfieri M; de Crecchio G
Eur J Ophthalmol; 2019 Mar; 29(2):239-243. PubMed ID: 29991290
[TBL] [Abstract][Full Text] [Related]
4. Vascular remodeling of choroidal neovascularization in older myopic patients treated with ranibizumab.
Cohen SY; Tabary S; El Ameen A; Mrejen S; Quentel G; Giocanti-Auregan A
Graefes Arch Clin Exp Ophthalmol; 2019 Mar; 257(3):485-493. PubMed ID: 30535969
[TBL] [Abstract][Full Text] [Related]
5. Vascular endothelial growth factor inhibitors for predominantly Caucasian myopic choroidal neovascularization: 2-year treatment outcomes in clinical practice: data from the Fight Retinal Blindness! Registry.
Gabrielle PH; Nguyen V; Creuzot-Garcher C; Miguel L; Alforja S; Sararols L; Casaroli-Marano RP; Zarranz-Ventura J; Gillies M; Arnold J; Barthelmes D
Acta Ophthalmol; 2022 Feb; 100(1):e288-e296. PubMed ID: 33960115
[TBL] [Abstract][Full Text] [Related]
6. Effect of intravitreal injection of aflibercept or ranibizumab on chorioretinal atrophy in myopic choroidal neovascularization.
Sayanagi K; Uematsu S; Hara C; Wakabayashi T; Fukushima Y; Sato S; Ikuno Y; Nishida K
Graefes Arch Clin Exp Ophthalmol; 2019 Apr; 257(4):749-757. PubMed ID: 30643966
[TBL] [Abstract][Full Text] [Related]
7. FACTORS INFLUENCING VISUAL ACUITY IN PATIENTS RECEIVING ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR FOR MYOPIC CHOROIDAL NEOVASCULARIZATION.
Iacono P; Battaglia Parodi M; Selvi F; Parravano MC; Chiaravalloti A; Varano M; Bandello F
Retina; 2017 Oct; 37(10):1931-1941. PubMed ID: 28033235
[TBL] [Abstract][Full Text] [Related]
8. Two different initial treatment regimens of ranibizumab in myopic choroidal neovascularization: 12-month results from a randomized controlled study.
Li S; Ding X; Sun L; Zhao X; Zhang A; Lyu C; Liu B; Zhang J; Jin C; Lu L
Clin Exp Ophthalmol; 2019 Mar; 47(2):250-258. PubMed ID: 30345611
[TBL] [Abstract][Full Text] [Related]
9. Outcome Predictors of SD-OCT-Driven Intravitreal Ranibizumab in Choroidal Neovascularization due to Myopia.
Guichard MM; Peters G; Tuerksever C; Pruente C; Hatz K
Ophthalmologica; 2020; 243(2):154-162. PubMed ID: 31387095
[TBL] [Abstract][Full Text] [Related]
10. Structural and optical coherence tomography angiography in myopic choroidal neovascularization: Agreement with conventional fluorescein angiography.
Iacono P; Giorno P; Varano M; Parravano M
Eur J Ophthalmol; 2021 Jan; 31(1):149-157. PubMed ID: 31619075
[TBL] [Abstract][Full Text] [Related]
11. Long-term follow-up of choroidal neovascularization in pathological myopia treated with intravitreal ranibizumab.
Ladaique M; Dirani A; Ambresin A
Klin Monbl Augenheilkd; 2015 Apr; 232(4):542-7. PubMed ID: 25902117
[TBL] [Abstract][Full Text] [Related]
12. FIVE-YEAR OUTCOMES OF INTRAVITREAL INJECTION OF RANIBIZUMAB FOR THE TREATMENT OF MYOPIC CHOROIDAL NEOVASCULARIZATION.
Wu TT; Kung YH
Retina; 2017 Nov; 37(11):2056-2061. PubMed ID: 28590318
[TBL] [Abstract][Full Text] [Related]
13. CHOROIDAL THICKNESS AND CHORIORETINAL ATROPHY IN MYOPIC CHOROIDAL NEOVASCULARIZATION WITH ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY.
Lee JH; Lee SC; Kim SH; Koh HJ; Kim SS; Byeon SH; Lee CS
Retina; 2017 Aug; 37(8):1516-1522. PubMed ID: 27798519
[TBL] [Abstract][Full Text] [Related]
14. LONG-TERM OUTCOMES OF RANIBIZUMAB TREATMENT OF MYOPIC CHOROIDAL NEOVASCULARIZATION IN EAST-ASIAN PATIENTS FROM THE RADIANCE STUDY.
Tan NW; Ohno-Matsui K; Koh HJ; Nagai Y; Pedros M; Freitas RL; Macfadden W; Lai TY
Retina; 2018 Nov; 38(11):2228-2238. PubMed ID: 28961671
[TBL] [Abstract][Full Text] [Related]
15. Nine-Year Outcome of Ranibizumab Monotherapy for Choroidal Neovascularization Secondary to Pathologic Myopia.
Pastore MR; Capuano V; Bruyère E; Miere A; Corbelli E; Querques L; Tognetto D; Bandello F; Querques G; Souied EH
Ophthalmologica; 2018; 239(2-3):133-142. PubMed ID: 29268267
[TBL] [Abstract][Full Text] [Related]
16. FIVE-YEAR OUTCOMES OF INTRAVITREAL RANIBIZUMAB FOR CHOROIDAL NEOVASCULARIZATION IN PATIENTS WITH PATHOLOGIC MYOPIA.
Onishi Y; Yokoi T; Kasahara K; Yoshida T; Nagaoka N; Shinohara K; Kaneko Y; Suga M; Uramoto K; Ohno-Tanaka A; Ohno-Matsui K
Retina; 2019 Jul; 39(7):1289-1298. PubMed ID: 29746414
[TBL] [Abstract][Full Text] [Related]
17. Long-term outcomes of the intravitreal injection of ranibizumab for the treatment of choroidal neovascularization secondary to pathologic myopia.
Wasiluk E; Wojnar M; Obuchowska I; Mariak Z
Int Ophthalmol; 2020 Apr; 40(4):833-839. PubMed ID: 31788714
[TBL] [Abstract][Full Text] [Related]
18. Features of optical coherence tomography predictive of choroidal neovascularisation treatment response in pathological myopia in association with fluorescein angiography.
Lee DH; Kang HG; Lee SC; Kim M
Br J Ophthalmol; 2018 Feb; 102(2):238-242. PubMed ID: 28600301
[TBL] [Abstract][Full Text] [Related]
19. Retinal pigmental epithelium elevation and external limiting membrane interruption in myopic choroidal neovascularization: correlation with activity.
Ding X; Zhan Z; Sun L; Yang Y; Li S; Zhang A; Luo X; Lu L
Graefes Arch Clin Exp Ophthalmol; 2018 Oct; 256(10):1831-1837. PubMed ID: 29982899
[TBL] [Abstract][Full Text] [Related]
20. Treatment Patterns for Myopic Choroidal Neovascularization in the United States: Analysis of the IRIS Registry.
Willis J; Morse L; Vitale S; Parke DW; Rich WL; Lum F; Cantrell RA
Ophthalmology; 2017 Jul; 124(7):935-943. PubMed ID: 28372860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
